Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Sell
1,575
-47
-3% -$7.64K 0.02% 280
2025
Q4
$316K Buy
1,622
+162
+11% +$38.6K 0.03% 229
2025
Q3
$411K Hold
1,460
0.03% 202
2025
Q2
$319K Buy
+1,460
New +$236K 0.03% 213
2025
Q1
Sell
-1,310
Closed -$218K 241
2024
Q4
$218K Hold
1,310
0.02% 289
2024
Q3
$223K Buy
+1,310
New +$190K 0.02% 238
2023
Q1
Sell
-8,174
Closed -$668K 475
2022
Q4
$668K Sell
8,174
-8,784
-52% -$668K 0.06% 170
2022
Q3
$1.03M Buy
16,958
+1,650
+11% +$121K 0.09% 117
2022
Q2
$1.07M Buy
15,308
+1,215
+9% +$88.9K 0.09% 122
2022
Q1
$1.17M Sell
14,093
-1,225
-8% -$99.2K 0.08% 136
2021
Q4
$1.34M Buy
+15,318
New +$1.44M 0.1% 87

Other funds holding ORCL

American Trust's ORCL Position: Q1 2026 in Review

American Trust reduced its Oracle (ORCL) stake by 2.9% in Q1 2026, selling an estimated $7.64K and leaving 1,575 shares worth $232K. The position accounts for 0.02% of the portfolio, ranked #280.

American Trust first reported a position in ORCL in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.34M in Q4 2021. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • American Trust held 1,575 shares of Oracle worth $232K as of Q1 2026.
  • American Trust sold 47 Oracle shares in Q1 2026, an estimated $7.64K.
  • Oracle made up 0.02% of American Trust's portfolio in Q1 2026, its #280 holding.
  • American Trust first reported a position in Oracle in Q4 2021 and has held it in 11 quarters since.
  • American Trust's Oracle position peaked at $1.34M in Q4 2021.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.